Nobuhiro Yagi
Director/Board Member at Kyoto Drug Discovery & Development Co., Ltd.
Profile
Nobuhiro Yagi currently works at Kyoto Drug Discovery & Development Co., Ltd., as Director, Kyoto Fusioneering Ltd., as Director, aceRNA Technologies, Inc., as Outside Director from 2018, and Kyoto University Innovation Capital Co., Ltd., as Executive Manager from 2016.
Nobuhiro Yagi active positions
| Companies | Position | Start |
|---|---|---|
Kyoto Drug Discovery & Development Co., Ltd.
 Kyoto Drug Discovery & Development Co., Ltd. BiotechnologyHealth Technology Kyoto Drug Discovery & Development Co., Ltd. engages in research and development of pharmaceuticals, diagnostics, regenerative medicine products and medical equipment. The company was founded by Noriyuki Kuno and Kunihiro Musashi on May 15, 2015 and is headquartered in Kyoto, Japan. | Director/Board Member | - |
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 2016-07-31 |
aceRNA Technologies, Inc.
 aceRNA Technologies, Inc. Internet Software/ServicesTechnology Services aceRNA Technologies, Inc. operates a drug development platform. The company is based in Kyoto, Japan. The Japanese company was founded in 2018 by Teruo Suzumu, Hirohide Saito. | Director/Board Member | 2018-03-31 |
Kyoto Fusioneering Ltd.
 Kyoto Fusioneering Ltd. Engineering & ConstructionIndustrial Services Kyoto Fusioneering Ltd. is a startup founded in 2019 by Richard Pearson, Taka Nagao, and Satoshi Konishi. The company is based in Uji, Japan, and uses the world's most advanced technology developed at Kyoto University to achieve its vision of a future powered by nuclear fusion energy. The Japanese company aims to solve the world's challenges by developing the ultimate energy solution, nuclear fusion. The company name "fusioneering" is a combination of "fusion" and "engineering". Taka Nagao has been the CEO since 2019. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kyoto Drug Discovery & Development Co., Ltd.
Kyoto Drug Discovery & Development Co., Ltd. BiotechnologyHealth Technology Kyoto Drug Discovery & Development Co., Ltd. engages in research and development of pharmaceuticals, diagnostics, regenerative medicine products and medical equipment. The company was founded by Noriyuki Kuno and Kunihiro Musashi on May 15, 2015 and is headquartered in Kyoto, Japan. | Health Technology |
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
aceRNA Technologies, Inc.
aceRNA Technologies, Inc. Internet Software/ServicesTechnology Services aceRNA Technologies, Inc. operates a drug development platform. The company is based in Kyoto, Japan. The Japanese company was founded in 2018 by Teruo Suzumu, Hirohide Saito. | Technology Services |
Kyoto Fusioneering Ltd.
Kyoto Fusioneering Ltd. Engineering & ConstructionIndustrial Services Kyoto Fusioneering Ltd. is a startup founded in 2019 by Richard Pearson, Taka Nagao, and Satoshi Konishi. The company is based in Uji, Japan, and uses the world's most advanced technology developed at Kyoto University to achieve its vision of a future powered by nuclear fusion energy. The Japanese company aims to solve the world's challenges by developing the ultimate energy solution, nuclear fusion. The company name "fusioneering" is a combination of "fusion" and "engineering". Taka Nagao has been the CEO since 2019. | Industrial Services |
- Stock Market
- Insiders
- Nobuhiro Yagi
